← The Wire
MISTNasdaq
Milestone Pharmaceuticals Inc.
Pharmaceutical Preparations · A8 · CIK 1408443
Develops and commercializes innovative cardiovascular medicines, including the self-administered nasal spray CARDAMYST for PSVT
red 8-K · 90d
$158M
Market cap
$1.33
Last close
+7.3%
1D
+1.5%
5D
2.2M
Volume
Price · last 39 sessions-29.8%
May 4L $1.21 · H $1.97Jun 29
145
Total filings
Jun 15, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 15, 20268-KResults of OperationsMay 13, 202610-Q10-QMay 13, 2026DEFA14ADEFA14AApr 30, 2026DEF 14AFORM DEF 14AApr 30, 20268-KResults of OperationsMar 20, 202610-K10-KMar 20, 20268-KCompany UpdateJan 26, 20268-KCompany UpdateJan 13, 20268-KCompany UpdateJan 6, 20268-KReg FD Disclosure · Company UpdateDec 15, 20258-KResults of OperationsNov 12, 202510-Q10-QNov 12, 20258-KResults of OperationsAug 12, 202510-Q10-QAug 12, 20258-KMaterial Agreement · Company UpdateJul 14, 2025424B5424B5Jul 14, 2025424B5424B5Jul 11, 20258-KMaterial Agreement · Company UpdateJul 11, 20258-KCompany UpdateJun 16, 20258-KExecutive Change · Shareholder VoteJun 12, 20258-KResults of OperationsMay 14, 202510-Q10-QMay 14, 2025DEFA14ADEFA14AApr 30, 2025DEF 14ADEF 14AApr 30, 20258-KCompany UpdateMar 28, 20258-KCompany UpdateMar 19, 2025424B5424B5Mar 18, 20258-KMaterial Agreement · Company UpdateMar 18, 20258-KResults of OperationsMar 13, 202510-K10-KMar 13, 20258-KReg FD DisclosureFeb 25, 20258-KResults of OperationsNov 12, 202410-Q10-QNov 12, 20248-KExecutive Change · Shareholder VoteSep 4, 20248-KResults of OperationsAug 8, 202410-Q10-QAug 8, 2024DEFA14ADEFA14AJul 15, 2024DEFA14ADEFA14AJul 15, 2024DEF 14ADEF 14AJul 15, 20248-KExecutive Change · Material AgreementJul 15, 20248-KCompany UpdateMay 29, 20248-KResults of OperationsMay 13, 202410-Q10-QMay 13, 202410-K/AFORM 10-K/AApr 29, 20248-KCompany UpdateApr 8, 20248-KCompany UpdateMar 28, 20248-KResults of OperationsMar 21, 202410-K10-KMar 21, 20248-KMaterial Agreement · Company UpdateMar 4, 2024424B5424B5Mar 1, 2024424B5424B5Feb 28, 20248-KCompany UpdateFeb 26, 20248-KCompany UpdateDec 26, 20238-KResults of OperationsNov 13, 20238-KReg FD Disclosure · Company UpdateNov 13, 202310-Q10-QNov 13, 2023SC 13DTHE SCHEDULE 13DNov 9, 20238-KReg FD DisclosureNov 7, 20238-KReg FD Disclosure · Company UpdateOct 24, 20238-KResults of OperationsAug 10, 202310-Q10-QAug 10, 20238-KShareholder Vote · Company UpdateJun 9, 2023424B5424B5May 31, 202310-K/A10-K/AMay 31, 20238-KResults of OperationsMay 11, 202310-Q10-QMay 11, 2023DEFA14ADEF 14AApr 28, 2023DEF 14ADEF 14AApr 28, 20238-KNew Debt / Obligation · Equity IssuanceMar 31, 20238-KResults of OperationsMar 29, 202310-K10-KMar 29, 20238-KMaterial Agreement · Reg FD DisclosureMar 28, 20238-KExecutive Change · Material AgreementMar 27, 20238-KReg FD DisclosureMar 10, 20238-KReg FD DisclosureMar 7, 2023SC 13GSC 13GJan 19, 20238-KExecutive Change · Reg FD DisclosureDec 6, 20228-KResults of OperationsNov 10, 202210-Q10-QNov 10, 2022
Insider Activity
In the 90 days to Jan 26, 2026: 5 sold $1.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 26, 2026 | Oliveto JosephPresident and CEO | Sell | 34,523 | $1.93 | $67K |
| Jan 26, 2026 | Bharucha DavidChief Medical Officer | Sell | 12,245 | $1.93 | $24K |
| Jan 26, 2026 | Nelson Jeffrey EdwardChief Operating Officer | Sell | 12,245 | $1.93 | $24K |
| Jan 26, 2026 | Hasija AmitCFO & EVP of Corp. Development | Sell | 12,245 | $1.93 | $24K |
| Jan 26, 2026 | Muller LorenzChief Commercial Officer | Sell | 11,180 | $1.93 | $22K |
| Jan 8, 2026 | Oliveto JosephPresident and CEO | Sell | 43,000 | $2.25 | $97K |
| Jan 7, 2026 | Oliveto JosephPresident and CEO | Sell | 500 | $2.25 | $1K |
| Dec 15, 2025 | Oliveto JosephPresident and CEO | Sell | 133,054 | $2.32 | $309K |
| Dec 15, 2025 | Bharucha DavidChief Medical Officer | Sell | 58,007 | $2.32 | $135K |
| Dec 15, 2025 | Hasija AmitCFO & EVP of Corp. Development | Sell | 58,007 | $2.32 | $135K |
| Dec 15, 2025 | Nelson Jeffrey EdwardChief Operating Officer | Sell | 58,007 | $2.32 | $135K |
| Dec 15, 2025 | Muller LorenzChief Commercial Officer | Sell | 53,566 | $2.32 | $124K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance